ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT02746757
Date of registration:	18/04/2016
Prospective Registration:	No
Primary sponsor:	Karolinska Institutet
Public title:	Glucagon Like Peptide-1 in Remote Ischemic Conditioning
Scientific title:	The Role of Glucagon Like Peptide-1 in the Protective Effect of Remote Ischemic Conditioning During Ischemia-reperfusion
Date of first enrolment:	May 2015
Target sample size:	12
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT02746757
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).
Phase:	N/A

Countries of recruitment
Sweden

Contacts

Key inclusion & exclusion criteria

Inclusion Criteria:

Healthy male volunteers -

Exclusion Criteria:

-

Age minimum: 18 Years
Age maximum: 60 Years
Gender: Male

Health Condition(s) or Problem(s) studied

Healthy Volunteers

Intervention(s)

Drug: Exendin 9-39

Other: Remote conditioning

Primary Outcome(s)

Change in endothelium dependent vasodilatation [Time Frame: 20 min post-reperfusion]

Secondary Outcome(s)

Secondary ID(s)

RIPC GLP-1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.